COMPARE · Data as of August 27, 2026

BGC vs XP

Verdict: Side-by-side breakdown using the Bull Rankings model. BGC scored 77.0, XP scored 72.0 — BGC leads.
Compare another set
Different reporting periods. BGC's fundamentals are as of March 2026, but XP's are as of December 2025 — a 3-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
BGC
BGC Group, Inc.
Capital Markets · Financial strength
48.1Fin
$12.10 · $5.8B
fundamentals as of
Strength gap
19.5
XP leads
XP
XP Inc.
Capital Markets · Financial strength
67.6Fin
$17.80 · $9.0B
fundamentals as of
  • CheapestXP8.8x
  • Fastest growthBGC+30.9%
THE BULL RANKINGS SCORECARD48.1/ 100 · FIN STRENGTHPEER MEDIANFINANCIAL48.1
THE BULL RANKINGS SCORECARD67.6/ 100 · FIN STRENGTHPEER MEDIANFINANCIAL67.6
cheap & fastrevenue growth →← cheaper (lower multiple)-3%41%3.8x35xBGCXP

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

RevBGC+30.9%XP+7.3%
P/EBGC30.3xXP8.8x
ROEBGC15.9%XP22.6%
P/BBGC5.17XP1.96
YieldBGC0.7%XP1.2%
BGC
XP
+30.9%A
Rev
+7.3%B
30.3xC
P/E
8.8xA-
15.9%B+
ROE
22.6%A-
5.17D
P/B
1.96B
0.7%C
Yield
1.2%C+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
BGCBGC Group, Inc.
Capital Markets · $12.10 · beta 0.95
Why now
Capital Markets · market cap $5.8b. 6% off the 52-week high of $12.89. Revenue growing +31% — in hypergrowth territory.
Moat
ROE 16% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
Trailing P/E 30x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. Credit-cycle exposure — provisions tend to lag actual loan deterioration by 2-3 quarters; a sharp uptick in net charge-offs is a leading indicator the market often misses until it's already priced.
XPXP Inc.
Capital Markets · $17.80 · beta 1.10
Why now
Capital Markets · market cap $9.0b. Down 23% from 52-week high of $23.13 — deep drawdown territory. PEG 0.66 — paying under fair value for the growth rate. 9 sell-side analysts rate this a Buy with a mean 1-yr target of $22.17 (implying +25% upside).
Moat
Net margin 29% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 23% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. Financial moat — scale of deposit base / underwriting franchise plus regulatory capital advantages. The largest players compound book value through cycles that erase smaller competitors.
Risk
D/E 6.42 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Balance-sheet financial — book value, net interest margin, and credit loss provisions are the lever points; a rates regime change or a deterioration in the loan book moves the stock more than EPS does.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.